Andrew Sloan, MD
Neurological Surgery · Dayton, OHNPI 1952317554
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $24,608 of the $32,536 with a category attached, or 75.6%. Medtronic accounts for 60.4% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $12,431 and has fallen 99.5% since, to $66 in 2025.
Across 55 payments — averaging $591.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$20K
- Medexus Pharma, Inc.$7K
- Monteris Medical Corporation$4K
- Biogen$1K
- GT Medical Technologies, Inc$140
- Carl Zeiss Meditec USA, Inc.$116
- plus $454 from 9 others
Across 16 payments — averaging $50,996 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$792K
- Monteris Medical Corporation$24K
Across 7 payments — averaging $251.11 each. An ownership or investment interest held by the physician or an immediate family member.
- Surgical Theater. Inc.$2K
What the payments were for
- Consulting fees$24,60876%
- Speaking & faculty fees$6002%
- Travel & lodging$5,69317%
- Food & beverage$1,5965%
- Education$400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 30 | $19,643 |
| Medexus Pharma, Inc. | 2 | $6,800 |
| Monteris Medical Corporation | 9 | $4,276 |
| Biogen | 1 | $1,108 |
| GT Medical Technologies, Inc | 1 | $140 |
| Carl Zeiss Meditec USA, Inc. | 1 | $116 |
| Insightec,inc | 1 | $108 |
| Brainlab, Inc. | 1 | $97 |
| Smith+Nephew | 2 | $80 |
| Lilly USA, LLC | 2 | $50 |
| Omniscient Neurotechnology America Ltd | 1 | $28 |
| Globus Medical | 1 | $26 |
| AstraZeneca | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $24 |
| Haemonetics Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VISUALASE$9,762
- StealthStation$7,406
- Gleolan$6,800
- Neuroblate$4,133
- STEALTHSTATION S8 PLATFORM$1,859
- GammaTile$140
- CONVIVO$116
- Exablate$108
How this compares
$32,536 in reported general payments places this provider in the 80th percentile of 301 neurological surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurological surgery in Dayton
- Michael VerdonDayton$46K
- James RobbinsDayton$27K
- Abdi MohitCleveland$884K
- William ZerickWesterville$778K
- Christian BonassoColumbus$656K
- Russell LonserColumbus$419K
- Zachary TempelCincinnati$351K
- Jamal TahaCenterville$341K
- Chris KarasColumbus$339K
- Kamal WoodsMiamisburg$268K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.